ストックスクリーナーアプリを入手
8.471
2.46%
-0.214
前日終値:
$8.685
開ける：
$8.9709
24時間の取引高:
55,115
Relative Volume:
0.49
時価総額：
$26.93M
収益：
-
当期純損益:
$-68.80M
株価収益率:
-7.2402
EPS:
-1.17
ネットキャッシュフロー:
$-59.06M
1週間 パフォーマンス:
+6.55%
1か月 パフォーマンス:
+19.99%
6か月 パフォーマンス:
+2,241%
1年 パフォーマンス:
+1,336%
1日の値動き範囲:
$8.00
$9.00
1週間の範囲:
$7.84
$9.00
52週間の値動き範囲:
$0.257
$9.00
Passage Bio Inc Stock (PASG) Company Profile
名前
Passage Bio Inc
セクター
電話
(267) 866-0312
住所
ONE COMMERCE SQUARE, PHILADELPHIA, PA
PASG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PASG
Passage Bio Inc
|
8.471 | 27.61M | 0 | -68.80M | -59.06M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Passage Bio Inc Stock (PASG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-29 | 再開されました | Wedbush | Outperform |
| 2024-09-03 | 開始されました | Rodman & Renshaw | Buy |
| 2022-03-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-01-19 | ダウングレード | Goldman | Buy → Neutral |
| 2021-07-01 | 開始されました | Raymond James | Outperform |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-03-04 | アップグレード | Goldman | Neutral → Buy |
| 2021-02-04 | 開始されました | Guggenheim | Buy |
| 2021-01-25 | 開始されました | Wedbush | Outperform |
| 2021-01-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-12-11 | 開始されました | Citigroup | Neutral |
| 2020-08-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-06-25 | ダウングレード | Goldman | Buy → Neutral |
| 2020-03-25 | 開始されました | Chardan Capital Markets | Buy |
| 2020-03-24 | 開始されました | Cowen | Outperform |
| 2020-03-24 | 開始されました | Goldman | Buy |
| 2020-03-24 | 開始されました | JP Morgan | Overweight |
すべてを表示
Passage Bio Inc (PASG) 最新ニュース
Why Passage Bio Inc. stock could rally in 2025July 2025 Breakouts & Safe Capital Growth Tips - newser.com
What’s next for Passage Bio Inc. stock price2025 Stock Rankings & Safe Entry Trade Reports - newser.com
What the charts say about Passage Bio Inc. todayWeekly Risk Report & High Yield Equity Trading Tips - newser.com
How to build a custom watchlist for Passage Bio Inc.July 2025 Drop Watch & Free Weekly Watchlist of Top Performers - newser.com
Full technical analysis of Passage Bio Inc. stockWeekly Profit Analysis & Real-Time Chart Pattern Alerts - newser.com
Key resistance and support levels for Passage Bio Inc.July 2025 Sentiment & Detailed Earnings Play Strategies - newser.com
What analysts say about Passage Bio Inc stockTechnical Pattern Recognition & Consistently Superior Profits - earlytimes.in
Passage Bio Inc. stock daily chart insightsTake Profit & Weekly Watchlist of Top Performers - newser.com
How buybacks impact Passage Bio Inc. stock valueTrade Risk Report & AI Driven Stock Reports - newser.com
Passage Bio Inc Stock Analysis and ForecastTrend Following Strategies & Rapid Portfolio Expansion - earlytimes.in
Is it too late to sell Passage Bio Inc.Bull Run & Weekly High Momentum Picks - newser.com
Is Passage Bio Inc. stock poised for growthWeekly Risk Report & Safe Capital Preservation Plans - newser.com
Is Passage Bio Inc. reversing from oversold territory2025 Pullback Review & High Accuracy Trade Signal Alerts - newser.com
Passage Bio (NASDAQ:PASG) Trading Up 1.8% – Time to Buy? - Defense World
Is Passage Bio Inc a good long term investmentMACD Histogram Signals & Investment Risk Management Tips - earlytimes.in
How institutional ownership impacts Passage Bio Inc. stockWeekly Trend Report & Safe Swing Trade Setups - newser.com
GM1 Gangliosidosis Market: Epidemiology, Therapies, Companies – DelveInsight | Featuring Passage Bio Inc., Gain Therapeutics, Sio Gene Therapies - The Globe and Mail
GM1 Gangliosidosis Market: Epidemiology, Therapies, - openPR.com
Retail Surge: Can Passage Bio Inc ride the EV waveWeekly Trading Summary & High Accuracy Trade Signal Alerts - خودرو بانک
Can machine learning forecast Passage Bio Inc. recoveryJuly 2025 Final Week & Free Expert Approved Momentum Trade Ideas - newser.com
Passage Bio Inc (PASG) 財務データ
収益
当期純利益
現金流量
EPS
Passage Bio Inc (PASG) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner |
Sep 15 '25 |
Buy |
6.99 |
11,900 |
83,175 |
623,704 |
| Lynx1 Capital Management LP | 10% Owner |
Sep 11 '25 |
Buy |
6.96 |
325 |
2,261 |
592,021 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 24 '25 |
Buy |
5.71 |
66,423 |
379,455 |
591,696 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 23 '25 |
Buy |
5.74 |
49,302 |
283,033 |
525,273 |
| Lynx1 Capital Management LP | 10% Owner |
Jul 22 '25 |
Buy |
5.44 |
13,123 |
71,338 |
475,971 |
5.74%
大文字化:
|
ボリューム (24 時間):